
The Quiet Period Checklist: What to Do Before Q4 Earnings
What Is a Quiet Period, And What It Isn’t A quiet period is a self-imposed window when a public company limits what it says to

What Is a Quiet Period, And What It Isn’t A quiet period is a self-imposed window when a public company limits what it says to

Why Analyst Days Fail on Execution, Not Content Most post-mortems on a disappointing Analyst Day point to the wrong culprit. Teams blame the strategy slide,
Why EM Corporate Access Isn’t Developed-Market Access With a Passport Corporate access programs built for the S&P 500 or FTSE 350 don’t scale down into
The End of Static Targeting: Why CRM Alone No Longer Cuts It Static CRM targeting means building investor lists from past meeting logs, manually tagged
The Unbundling Era Is Over: Why 2026 Marks a Structural Shift MiFID II’s 2018 unbundling mandate forced investment firms to pay for research separately from

Non-Deal Roadshows Are a Capital-Allocation Decision, Not a Calendar Task A non-deal roadshow schedules meetings between company executives and investors outside any securities offering. IR
What Is Buy-Side Research? (And How It Differs From Sell-Side) Buy-side research is the analysis institutional investors, asset managers use to decide what to buy,
What Is a Non-Deal Roadshow, and Why It’s Different From a Deal Roadshow A non-deal roadshow (NDR) is a series of one-on-one or small-group meetings
Investor Day vs. Analyst Day: The Core Difference An Investor Day and an Analyst Day are not legally defined terms. No regulator publishes a rulebook
From Novelty to Necessity: Why AI Is No Longer Optional in IR AI in investor relations has moved past the pilot-project phase. The Conference Board